Skip to main content

Advertisement

Table 2 Baseline severity of psychological and immunosuppression-related symptoms and levels of health-related quality and treatment adherence

From: Pilot testing a model of psychological care for heart transplant recipients

Variable Intervention
n = 6
Median (IQR)
Control
n = 7
Median (IQR)
PHQ-9 score 9 (7–13) 10 (8–18)
GAD-7 score 4.5 (2–7) 8 (7–10)
K-10 score 19.5 (17–21) 20 (16–25)
Difficulty with keeping scheduled follow-up visitsd 5 (4–5) 4 (4–5)
Difficulty with following a regular exercise programd 2.5 (1–4) 2 (1–3)
Difficulty with following a healthy and balanced dietd 4 (2–4) 2 (2–3)
Difficulty with having tests done as scheduledd 5 (5–5) 4 (4–5)
Difficulty with taking all medicines as prescribedd 5 (5–5) 4 (4–5)
Difficulty with side effects of medicinesd 4.5 (2–5) 4 (3–4)
Immunosuppression treatment adherencea 100 (100–100) 95 (90–98)
Number of immunosuppression-related symptoms experienced ‘almost always’ or ‘always’b 6.5 (3–12) 7 (3–12)
Physical functioningc 70 (25–95) 40 (15–55)
Role limitations due to physical healthc 50 (0–75) 25 (0–75)
Role limitations due to emotional problemsc 0 (0–100) 100 (0–100)
Energy/fatiguec 27.5 (5–50) 30 (20–35)
Emotional well-beingc 70 (64–72) 60 (60–64)
Social functioningc 50 (50–63) 50 (50–50)
Painc 36 (33–48) 50 (35–58)
General healthc 53 (50–55) 50 (40–50)
  1. IQR interquartile range, aRating of overall treatment adherence over the past 2 weeks on a scale of 0–100 (higher score = better adherence); bMTSOSD-59; cScores range from 0 to 100 with higher scores representing better health-related quality of life’; d1 = Very difficult, 5 = Very easy; PHQ-9 = Patient Health Questionnaire 9-item scale; GAD-7 = Generalized Anxiety Disorder 7-item scale; K-10 = Kessler Psychological Distress Scale